Design Therapeutics, Inc.DSGNNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank43
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P43
Within normal range
vs 2Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-7.51%
Q3 202523.17%
Q2 202513.84%
Q1 2025-71.00%
Q4 2024-3.46%
Q3 202416.56%
Q2 20249.60%
Q1 20241.49%
Q4 202312.08%
Q3 2023-5.00%
Q2 202320.66%
Q1 2023-13.86%
Q4 2022-8.23%
Q3 2022-27.20%
Q2 20226.15%
Q1 2022-24.24%
Q4 2021-4.92%
Q3 2021-7.79%
Q2 2021-127.13%
Q1 2021-30.51%
Q4 2020-48.78%
Q3 2020-46.98%
Q2 202050.85%
Q1 20200.00%